<DOC>
	<DOCNO>NCT02287584</DOCNO>
	<brief_summary>The primary objective study evaluate efficacy DSP-5423P compare placebo patient schizophrenia .</brief_summary>
	<brief_title>Confirmatory Study DSP-5423P Patients With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Patients schizophrenia diagnose DSM5 , diagnostic criterion Patients age 18 year old informed consent Patient understand objective procedure study provide write voluntarily consent participate study , etc . Patients fall contraindication list blonanserin ( LONASEN ) package insert Patients Parkinson disease Patients previously receive blonanserin , etc .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>